Biomarkers in descending thoracic aortic dissection

Sherene Shalhub; Anahita Dua; Jared Brooks

doi:10.1053/j.semvascsurg.2015.01.001

Biomarkers in descending thoracic aortic dissection

Semin Vasc Surg. 2014 Dec;27(3-4):196-9. doi: 10.1053/j.semvascsurg.2015.01.001. Epub 2015 Jan 16.

Authors

Sherene Shalhub¹, Anahita Dua², Jared Brooks³

Affiliations

¹ Division of Vascular Surgery, Department of Surgery, University of Washington, 1959 NE Pacific Street, Box 356410, Seattle, WA 98195-6410. Electronic address: shalhub@uw.edu.
² Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.
³ Division of Vascular Surgery, Department of Surgery, University of Washington, 1959 NE Pacific Street, Box 356410, Seattle, WA 98195-6410.

PMID: 26073830
DOI: 10.1053/j.semvascsurg.2015.01.001

Abstract

The clinical application of serum biomarkers (d-dimer, C-reactive protein) to predict the natural history of descending thoracic aortic dissection remains elusive. In this review, our current understanding of biomarkers in descending thoracic aortic dissection detection, predicting complications, and aiding in patient management is discussed.

Publication types

Review

MeSH terms

Aortic Aneurysm, Thoracic / blood*
Aortic Aneurysm, Thoracic / diagnosis
Aortic Aneurysm, Thoracic / therapy
Aortic Dissection / blood*
Aortic Dissection / diagnosis
Aortic Dissection / therapy
Biomarkers / blood
C-Reactive Protein / metabolism*
Fibrin Fibrinogen Degradation Products / metabolism*
Humans
Patient Selection
Predictive Value of Tests
Prognosis

Substances

Biomarkers
Fibrin Fibrinogen Degradation Products
fibrin fragment D
C-Reactive Protein